Global Dry Eye Syndrome Market to Reach US$ 7.5 Billion by 2032, Stimulated by Growing Usage of Electronic Devices

July 26, 2023 | Healthcare

According to the latest report by IMARC Group, titled “Dry Eye Syndrome Market Report by Disease Type (Evaporative Dry Eye Syndrome, Aqueous Dry Eye Syndrome), Drug Type (Anti-inflammatory Drugs, Lubricant Eye Drops, Autologous Serum Eye Drops), Product (Liquid Drops, Gel, Liquid Wipes, Eye Ointment, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2024-2032,” the global dry eye syndrome market size reached US$ 4.8 Billion in 2023. Dry Eye Syndrome is a common eye condition characterized by inadequate lubrication and moisture on the surface of the eye. It occurs when the tear glands fail to produce enough tears or when the tears evaporate too quickly, resulting in dryness, irritation, and discomfort. It includes symptoms such as a gritty or sandy sensation in the eyes, redness, stinging or burning sensations, excessive tearing, blurred vision, and sensitivity to light. There are several underlying causes of dry eye syndrome, including aging, hormonal changes, certain medications, medical conditions such as autoimmune disorders, environmental factors, and lifestyle choices. Some commonly used treatments include the use of artificial tears or lubricating eye drops to provide temporary relief.

Global Dry Eye Syndrome Market Trends:

Lifestyle changes and increased screen time is driving the global market. Moreover, with the widespread use of digital devices such as smartphones, tablets, and computers, individuals are exposed to prolonged periods of screen viewing, leading to decreased blink rates and increased evaporation of tears. This prolonged visual tasking and reduced blinking contribute to the development of dry eye symptoms, thereby fueling the demand for DES treatments. Besides, with the global population aging, the prevalence of DES is expected to increase, leading to a greater demand for effective treatments and management options. Furthermore, various environmental factors, such as pollution and dry climates, are augmenting the DES market as exposure to environmental pollutants, allergens, and irritants can trigger or exacerbate dry eye symptoms, thus catalyzing the market. Additionally, living in regions with dry climates or spending time in air-conditioned or heated environments can lead to increased evaporation of tears and worsened DES symptoms. Along with this, continual advancements in diagnostic technologies and techniques have improved the accuracy and efficiency of DES diagnosis, allowing for earlier detection and intervention. This is creating a positive market outlook. Looking forward, the market value is projected to reach US$ 7.5 Billion by 2032, expanding at a CAGR of 5% during 2024-2032.

Market Summary:

Based on the disease type, the market has been segmented into evaporative and aqueous dry eye syndromes. Currently, evaporative dry eye syndrome represents the largest market segment.
On the basis of the drug type, the market has been divided into anti-inflammatory drugs, lubricant eye drops, and autologous serum eye drops. Among these, anti-inflammatory drugs exhibit a clear dominance in the market.
Based on the product, the market has been bifurcated into liquid drops, gel, liquid wipes, eye ointment, and others. Among these, liquid eye drops account for the largest market share.
On the basis of the distribution channel, the market has been divided into hospital, retail and online pharmacies. Among these hospital pharmacies exhibits a clear dominance in the market.
Region-wise, the market has been segmented into North America, Europe, Asia Pacific, Middle East and Africa and Latin America. Among these, North America holds the leading position in the market.
The competitive landscape of the market has also been examined, with some of the key players Akorn Operating Company LLC, Alimera Science, Allergan plc., Auven Therapeutics, Bausch + Lomb Incorporated, GlaxoSmithKline plc, Nicox S.A., Novartis AG, Otsuka Holdings Co. Ltd., and Santen Pharmaceutical Co. Ltd.

Report Coverage:

Report Features	Details
Base Year of the Analysis	2023
Historical Period	2018-2023
Forecast Period	2024-2032
Units	US$ Billion
Segment Coverage	Disease Type, Drug Type, Product, Distribution Channel, Region
Region Covered	Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Companies Covered	Akorn Operating Company LLC, Alimera Science, Allergan plc., Auven Therapeutics, Bausch + Lomb Incorporated, GlaxoSmithKline plc, Nicox S.A., Novartis AG, Otsuka Holdings Co. Ltd., and Santen Pharmaceutical Co. Ltd.
Customization Scope	10% Free Customization
Report Price and Purchase Option	Single User License: US$ 2499 Five User License: US$ 3499 Corporate License: US$ 4499
Post-Sale Analyst Support	10-12 Weeks
Delivery Format	PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

Speak to our experienced analysts for insights on the current market scenarios.
Include additional segments and countries to customize the report as per your requirement.
Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
For further assistance, please connect with our analysts.

Global Dry Eye Syndrome Market to Reach US$ 7.5 Billion by 2032, Stimulated by Growing Usage of Electronic Devices

Purchase options

Single User License $2499
Five User License $3499
Corporate User License $4499

Inquire Before Buying

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Speak to an Analyst

Request Brochure

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.